Three Latham Partners Named to Forbes 2027 America’s Top AI Lawyers List
The inaugural list honors lawyers in private practice with a distinguished track record advising on artificial intelligence matters.
Latham’s Washington, D.C. office offers clients powerhouse corporate capabilities, regulatory insights, as well as litigation and trial strength.
We have built a remarkable track record of navigating the federal government — in the courts, the White House and Executive Branch agencies, as well as Congress. As a group, we draw on experience serving in a wide variety of senior roles within the federal government, so we can advise clients based on deep knowledge of the inner workings of government.
We regularly represent clients facing criminal, civil, and congressional investigations, litigation in all US courts, and the full range of commercial disputes. Our courtroom victories regularly earn Latham recognition from National Law Journal as among the very best litigators and trial lawyers in Washington.
Unique among firms in the capital, we combine classic litigation and regulatory practices with our premier transactional practices, which include the largest and most successful corporate/M&A, capital markets, private equity, and leveraged finance practices in Washington.
As one of the world’s largest pro bono providers, Latham takes on matters in nearly every area of public interest law. In Washington, D.C., some of our key pro bono causes include advocating for asylum seekers, reuniting immigrant and refugee families, and safeguarding tenants’ rights, veterans’ rights, and civil rights.
The inaugural list honors lawyers in private practice with a distinguished track record advising on artificial intelligence matters.
Three Latham teams earned recognition for winning dismissal of a copyright suit against Google, successfully defending Venture Global in a shareholder lawsuit, and securing dismissal with prejudice of a lawsuit filed against Voyager Technologies on the eve of its IPO.
Two Latham litigation teams recognized for securing a rare preliminary injunction in biosimilar patent litigation for J&J’s Jassen and a first-round dismissal with prejudice of a securities class action on behalf of VinFast.